Hoping To See Your Doctor Via Telemedicine? Here’s A Quick Guide.
All private health plans, Medicare, state Medicaid programs and the VA now cover some e-visits — albeit with restrictions.
The independent source for health policy research, polling, and news.
6,881 - 6,900 of 15,460 Results
All private health plans, Medicare, state Medicaid programs and the VA now cover some e-visits — albeit with restrictions.
The complexity of health insurance coverage rules, along with market trends that leave consumers open to more out-of-pocket costs, lead to mounting medical debt for consumers.
President Donald Trump is recommending that Congress approve his plan to take back about $7 billion in funding for the Children’s Health Insurance Plan. Experts are divided about whether it would have any effect.
Federal law prohibits them from using the coupons drugmakers offer to help patients cover their share of a medicine’s cost.
A provision of this massive legislation would provide funding to help agricultural groups set up association health plans — a longtime GOP-favored mechanism to reduce health insurance costs for small groups.
A combination of factors has led to an “astronomical” increase in mentally ill inmates, followed by increased efforts to identify those who need prescriptions. Some say the meds are underprescribed; others, that they are given inappropriately, without the benefit of comprehensive treatment.
The Centers for Medicare & Medicaid Services rejects a plan by Kansas to cap benefits at three years.
Restaurants, convenience stores, vending machines and pizza delivery services are among the businesses that will have to provide calories counts to consumers.
Tyler, Texas, and the surrounding county has the highest suicide rate among the state’s 25 most populous counties, and community leaders are determined to change that.
The saga of Martin Shkreli and Turing Pharmaceuticals focused a lot of attention on prescription drug prices, but no reversal of the exponential price increases for the lifesaving drug Daraprim resulted. The story offers an object lesson into the interworkings of the pharmaceutical market.
The scathing report cites a significant increase in cases of poor care — especially ones with the potential to cause serious injuries or death. A state lawmaker called the findings “very, very disturbing.”
A device called the Bridge is supposed to mitigate the misery of withdrawal sickness, but scientific evidence doesn't yet show that it works.
Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Talking Points Memo discuss the latest on states’ efforts to reshape their Medicaid programs, the kerfuffle over President Donald Trump’s medical records and comments by former Health and Human Services Secretary Tom Price about Congress’ repeal of the Affordable Care Act’s “individual mandate” penalty. Rovner also interviews Harvard professor Robert Blendon about the complex politics of health in the coming midterm elections.
Your health insurance might not cover items such as wheelchairs, walkers, crutches and braces, or you may have to deal with a supplier that has a contract with your insurer.
Companies pushed proton machines and counted on advertising, doctors and insurers to ensure a steady business treating cancer. But the dollars haven’t flowed in as expected.
The Golden State ranks near the bottom in its enrollment of eligible people in the food assistance program known as SNAP. Now state officials want to tap its robust Medicaid rolls to boost SNAP signups.
The former secretary of the Department of Health and Human Services says the law eliminating penalties for most people who don’t have insurance coverage will hurt the insurance marketplaces.
Getting prisoners to a medical facility can be difficult, so corrections officials are increasingly setting up telemedicine programs for specialized needs, such as psychiatric, cancer and cardiac care.
Across the country, community groups, hospitals and government agencies are stepping in to support the estimated 42 million family caregivers.
Denmark-based drugmaker Novo Nordisk has invested more in lobbying and doubled political donations since 2015.
© 2026 KFF